Upside & The Biotech Downturn
Is the current downturn a good buying opportunity for biotech stocks? And, if so, which biotech stocks are the most promising picks for aggressive investors?
Is the current downturn a good buying opportunity for biotech stocks? And, if so, which biotech stocks are the most promising picks for aggressive investors?
or these five stocks – which include a smaller cap mining company and a small-cap biotech play focused on developing specialty products for underserved patient populations read more!
“These are five stocks for very aggressive investors looking to get share-count leverage with stocks that have sizable upside potential,” declares the author of today’s… Read More »5 Aggressive Tech Plays Under $10
“These are five stocks for very aggressive investors looking to get share-count leverage with stocks that have sizable upside potential.”
It may be worthwhile to have a look at some of the most popular stocks on the Robinhood trading platform – especially those in the red-hot biotech space.
With year-to-date gains of 2300%, 3300% and 3400%, respectively, the three stocks that are the focus of today’s article – two biotechs and a molecular… Read More »With Gains Of 2300% Or More, Which Of These Best-Performing Coronavirus Stocks Are Buys?